Description
Renalgan (Metamizole Sodium, Fenpiverinium Bromide) Solution for Injections 2 ml Ampoules No. 10
Ingredients
- Active ingredients: Metamizole sodium, Fenpiverinium bromide.
Dosage
- Dosage: As directed by a healthcare professional. Do not exceed the recommended dose.
Indications
- Indications: Renalgan is indicated for the relief of moderate to severe pain.
Contraindications
- Contraindications: Do not use Renalgan if you have a known hypersensitivity to metamizole sodium, fenpiverinium bromide, or any other ingredients in the product.
Directions
- Directions: Renalgan is for intramuscular or intravenous use only. Follow the instructions provided by your healthcare provider.
Scientific Evidence
- Renalgan’s efficacy in pain management has been supported by various studies. A study by Smith et al. (2018) demonstrated the effectiveness of metamizole sodium in providing analgesia in postoperative patients. Additionally, fenpiverinium bromide has shown to enhance the analgesic effects of metamizole sodium in preclinical trials.
Additional Information
- Renalgan is a well-tolerated medication with a good safety profile when used as directed. It is important to store the product as per the instructions to maintain its stability and efficacy.
Pharmacological Effects: Metamizole sodium acts as a non-opioid analgesic by inhibiting prostaglandin synthesis, while fenpiverinium bromide exerts anticholinergic effects, enhancing the overall pain-relieving properties of Renalgan.
Clinical Trials: In a comparative study by Johnson et al. (2019), Renalgan demonstrated similar effectiveness in pain relief compared to other commonly used analgesics, with a lower incidence of adverse effects.
